Nuvation Bio NUVB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $83.23M+2,599% | $41.87M+633% | $13.12M+1,705% | $4.83M+237% | $3.08M— | ||
| $35.05M+42.5% | $34.3M+17.1% | $28.85M+4.0% | $27.36M-6.4% | $24.6M+91.6% | ||
| $38.31M+8.2% | $40.33M+54.3% | $37.36M+90.8% | $38.48M+138% | $35.39M+381% | ||
| $195K-3.9% | $166K-26.9% | $171K-27.8% | $182K-26.3% | $203K-23.4% | ||
| $79.35M+27.8% | $83.92M+34.2% | $66.21M+39.9% | $65.85M-86.0% | $62.09M+207% | ||
| $79.35M+27.8% | $83.92M+34.2% | $66.21M+39.9% | $65.85M-86.0% | $62.09M+207% | ||
| $6.71M+12,322% | $6.67M+7,398% | $6.53M+5,345% | $421K+219% | $54K— | ||
| $1.52M-73.7% | —— | $642K-90.7% | $4.58M-41.9% | $5.77M+6.7% | ||
| $5.4M+110% | -$36.59M+26.0% | -$55.79M-35.4% | -$59.01M+87.2% | -$53.24M-260% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $5.4M+110% | -$36.59M+26.0% | -$55.79M-35.4% | -$59.01M+87.2% | -$53.24M-260% | ||
| 6.5%+1,733pp | -87.4%+778pp | -425.2%+5,243pp | -1,220.9%+31,008pp | -1,726.2%— | ||
| $0.02+113% | -$0.11— | -$0.16-6.7% | -$0.17+91.0% | -$0.16-129% | ||
| 377.5M+11.5% | 341.5M+27.1% | 342.4M+25.2% | 340.7M+39.2% | 338.6M+54.6% | ||
| 347.3M+2.6% | 341.5M+27.1% | 342.4M+25.2% | 340.7M+39.2% | 338.6M+54.6% | ||
| $5.62M+168% | —— | —— | —— | $2.09M+18.3% | ||
| $3.91M+107% | -$36.64M+27.1% | -$55.6M-44.2% | -$59.88M+87.1% | -$53.26M-230% | ||
| -$1.22M-148% | $958K+149% | $501K-85.2% | -$225K+8.2% | -$493K+63.5% | ||
| -$12.32M-37.8% | $12.6M+72.0% | —— | —— | -$8.94M-692% | ||
| $4.44M+288% | $2.61M— | $669K-88.1% | $0— | $1.14M-78.3% | ||
| $44K-92.0% | $8.06M— | $501K— | $193.42M+6,939% | $548K+2,510% | ||
| -$43.64M-181% | $87.08M+68.2% | —— | $54.88M+60.1% | $54.18M+618% | ||
| $5.07M+112% | -$29.73M+35.8% | -$52.89M-70.1% | -$48.18M-29.1% | -$42.63M-171% | ||
| $438K-69.8% | —— | $698K— | -$14K— | $1.45M— | ||
| —— | $562.75K+2,165% | $562.75K+2,165% | $562.75K+2,165% | $562.75K+2,165% | ||
| $83.23M+2,599% | $41.87M+633% | $13.12M+1,705% | $4.83M+237% | $3.08M— | ||
| $375K— | —— | —— | —— | $0— | ||
| $268K+158% | $1.01M+189% | $313K-57.8% | $646K+536% | -$465K— | ||
| $4.42M+108% | -$33.5M+37.6% | -$55.9M-16.6% | -$63.23M+86.6% | -$58.69M-191% | ||
| 5.3%+1,908pp | -80%+861pp | -426.1%+6,168pp | -1,308.4%+31,454pp | -1,903.2%— | ||
| $3.88M+107% | -$34.04M+36.9% | -$56.43M-17.3% | -$63.59M+86.5% | -$59M-192% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvation Bio's profit margins?
- Gross margin is 54.3% and operating margin is -105.0%, with a -102.1% net margin.
- Where does Nuvation Bio's income statement data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.